Document is current

Article History

Received: 25 February 2025

Revised: 6 August 2025

Accepted: 9 August 2025

First Online: 25 August 2025

Compliance with ethical standards

:

: Motohiro Okumura reports no disclosures. Takeo Sato reports lecture fees from Pfizer Japan Inc. outside the submitted work. Yuki Tsujimoto reports no disclosures. Kenji Yamashiro subsidies from Teijin Pharma Ltd. and Ono Pharmaceutical Co. outside the submitted work. Yui Watanabe reports no disclosures. Satoshi Matsushima reports no disclosures. Tetsuya Shimizu reports no disclosures. Taku Gomi reports no disclosures. Hideto Kuribayashi reports no disclosures. Teppei Komatsu reports no disclosures. Kenichi Sakuta reports no disclosures. Kenichiro Sakai reports no disclosures. Hidetaka Mitsumura reports no disclosures. Yasuyuki Iguchi reports speaker honoraria from Abbvie, Alexion, Amgen, Biogen, Bristol Myers Squibb, Chugai, CSL-Behring, Daiichi-Sankyo, Eisai, Fujimoto Pharma, JB, Mitsubishi-Tanabe, Novartis, Otsuka, Pfizer, Sumitomo Dainippon, and Takeda, and his research is supported from Böehringer-Ingelheim, Fujimoto Pharma, Chugai, JB Daiichi-Sankyo, Mitsubishi-Tanabe, Medical Concierge Co., Ltd., NAGATANIEN Co., Ltd., Shionogi, and Otsuka. outside the submitted work.

: During the preparation of this work the authors used ChatGPT in order to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.